Allopurinol therapy in gout patients does not associate with beneficial cardiovascular outcomes: a population-based matched-cohort study
about
Allopurinol and the risk of atrial fibrillation in the elderly: a study using Medicare data.Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment optionsRegular inhaled corticosteroids in adult-onset asthma and the risk for future cancer: a population-based cohort study with proper person-time analysis.Effect of Urate-Lowering Therapy on All-Cause and Cardiovascular Mortality in Hyperuricemic Patients without Gout: A Case-Matched Cohort StudyCancer risk in patients aged 30 years and above with type 2 diabetes receiving antidiabetic monotherapy: a cohort study using metformin as the comparator.Allopurinol and the risk of stroke in older adults receiving medicareAllopurinol reduces the risk of myocardial infarction (MI) in the elderly: a study of Medicare claims.Risk and clinical predictors of osteoporotic fracture in East Asian patients with chronic obstructive pulmonary disease: a population-based cohort study.Hyperuricemia, gout, and cardiovascular disease: an update.Cardiovascular effects of urate-lowering therapies in patients with chronic gout: a systematic review and meta-analysis.Risk of Autoimmune Disease in Adults with Chronic Insomnia Requiring Sleep-Inducing Pills: A Population-Based Longitudinal Study.Allopurinol and the risk of incident peripheral arterial disease in the elderly: a US Medicare claims data study.Cardiac and renal protective effects of urate-lowering therapy.Negative correlation between serum uric acid and kidney URAT1 mRNA expression caused by resveratrol in rats.
P2860
Q31095161-70F72619-0BB9-44AC-BA35-A4FE55960913Q33864537-AC2B9BE6-07D8-42EF-BE2F-40BB2C380D1DQ35240254-035A6B28-14B7-440C-8812-72C616F1AE7AQ35873062-46615988-1EC2-4CE3-B8FD-FE692126F435Q36024628-A1A294EF-4A7E-4932-9752-8E780FFD376FQ36125528-F425FF2A-7313-4DCE-AB0A-3D360BAF6C81Q37274458-2219CF28-5142-4953-8BC5-67822118DB03Q37383393-3A0742E7-CF8D-4192-A079-844D9004C4C8Q38367776-278A36FC-C2DB-4DC4-85E5-68CA9BFA5E76Q38853112-6B6BFF56-0185-43E3-AF8C-EFB4A6DE2768Q38873631-FC15665B-91B2-43C8-882C-FABFA7433A81Q47589109-7F344465-C692-4359-A2F0-1B904DFA7844Q49616077-B9A52221-C3BE-4DA3-84BF-D3137D2502ADQ51005757-96C22567-F165-4B67-88A1-8828B7889C99
P2860
Allopurinol therapy in gout patients does not associate with beneficial cardiovascular outcomes: a population-based matched-cohort study
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Allopurinol therapy in gout pa ...... ion-based matched-cohort study
@ast
Allopurinol therapy in gout pa ...... ion-based matched-cohort study
@en
type
label
Allopurinol therapy in gout pa ...... ion-based matched-cohort study
@ast
Allopurinol therapy in gout pa ...... ion-based matched-cohort study
@en
prefLabel
Allopurinol therapy in gout pa ...... ion-based matched-cohort study
@ast
Allopurinol therapy in gout pa ...... ion-based matched-cohort study
@en
P2093
P2860
P1433
P1476
Allopurinol therapy in gout pa ...... ion-based matched-cohort study
@en
P2093
Jorng-Tzong Horng
Tzu-Hao Chang
Wan-Shan Chang
Ya-Fang Hong
P2860
P304
P356
10.1371/JOURNAL.PONE.0099102
P407
P577
2014-06-04T00:00:00Z